Research Topics
| M H KollefSummaryAffiliation: Washington University School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatmentGarrett E Schramm
Critical Care Specialty Resident, Barnes-Jewish Hospital, St. Louis, MO, USA
Crit Care Med 34:2069-74. 2006....
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycinMarin H Kollef
Pulmonary and Critical Care Division, Department of Internal Medicine, School of Medicine, Washington University, 660 South Euclid Avenue, St Louis, MO 63110, USA
Intensive Care Med 30:388-94. 2004..To assess the effect of baseline variables, including treatment, on clinical cure and survival rates in patients with Gram-positive, ventilator-associated pneumonia (VAP)...
Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first timeMarin Kollef
Pulmonary and Critical Care Division, Washington University School of Medicine, St Louis, Missouri 63110, USA
Drugs 63:2157-68. 2003..Antibacterial resistance is minimised by narrowing the antibacterial regimen once the pathogens and their susceptibility profiles are determined, and by employing the shortest course of therapy clinically acceptable...
The intensive care unit in antimicrobial resistanceM H Koleff
Department of Internal Medicine, Pulmonary and Critical Care Division, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110, USA
Postgrad Med 109:60-9. 2001..Among these wide-ranging strategies are adequate decontamination between patient contacts, antibiotic guidelines to limit unnecessary use, and use of combination antimicrobial therapy...
Optimizing antibiotic therapy in the intensive care unit settingM H Kollef
Department of Internal Medicine, Pulmonary and Critical Care Division, Washington University School of Medicine, Barnes Jewish Hospital, Campus Box 8052, 660 South Euclid Avenue, St Louis, MO 63110, USA
Crit Care 5:189-95. 2001..Only in this way can the impact of interventions aimed at improving antibiotic use (e.g. antibiotic rotation, de-escalation therapy) be evaluated at the local level...
The impact of the introduction of a rapid D-dimer assay on the diagnostic evaluation of suspected pulmonary embolismN M Goldstein
Campus Box 8052, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110, USA
Arch Intern Med 161:567-71. 2001..Although this hypothesis is anticipated to decrease the use of ventilation-perfusion (VQ) scans and other diagnostic tests for PE, it has not been tested in a "real-world" environment...
Antibiotic resistance in the intensive care unitM H Kollef
Campus Box 8052, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA
Ann Intern Med 134:298-314. 2001..Careful, focused attention to this problem at the local ICU level, using a multidisciplinary approach, will have the greatest likelihood of limiting the development and dissemination of antibiotic-resistant infections...
The impact of nosocomial infections on patient outcomes following cardiac surgeryM H Kollef
Department of Internal Medicine, Pulmonary and Critical Care, Washington University School of Medicine, St Louis, MO 63110, USA
Chest 112:666-75. 1997..To evaluate the relationship between nosocomial infections and clinical outcomes following cardiac surgery, and to identify risk factors for the development of nosocomial infections in this patient population...
Experience with a clinical guideline for the treatment of ventilator-associated pneumoniaE H Ibrahim
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA
Crit Care Med 29:1109-15. 2001..These findings suggest that similar types of guidelines employing local microbiological data can be used to improve overall antibiotic utilization for the treatment of ventilator-associated pneumonia...
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patientsM H Kollef
Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA
Chest 115:462-74. 1999..To evaluate the relationship between inadequate antimicrobial treatment of infections (both community-acquired and nosocomial infections) and hospital mortality for patients requiring ICU admission...
The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumoniaM H Kollef
Department of Internal Medicine, Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Chest 113:412-20. 1998..To determine the influence of mini-BAL culture results on subsequent changes in antibiotic therapy and patient outcomes...
Opinion: the clinical use of selective digestive decontaminationM H Kollef
Pulmonary and Critical Care Division, Washington University School of Medicine, St Louis, Missouri 63110, USA
Crit Care 4:327-32. 2000..Prolonged decontamination of the aerodigestive tract with topical antimicrobials does not appear to influence outcome, and should not be routinely employed...
Acute respiratory failure: a gender-based outcomes analysisM H Kollef
Pulmonary and Critical Care Division, Washington University School of Medicine, Campus Box 8052, 660 S Euclid Ave, St Louis, MO 63110, USA
J Gend Specif Med 1:24-30. 1998..To determine the influence of gender on patient outcomes and the delivery of medical care during mechanical ventilation for acute respiratory failure...
Is there a role for antibiotic cycling in the intensive care unit?M H Kollef
Department of Internal Medicine, Pulmonary and Critical Care Division, Washington University School of Medicine, St Louis, MO, USA
Crit Care Med 29:N135-42. 2001..The main goal of cycling is to allow resistance rates for specific antibiotics to decrease, or at least remain stable, when their use is periodically eliminated from the intensive care unit...
Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patientsM H Kollef
Department of Internal Medicine, Pulmonary and Critical Care Division, Washington University School of Medicine, St Louis, MO 63110, USA
Clin Infect Dis 31:S131-8. 2000..Further study evaluating the use of antibiotic practice guidelines and strategies to reduce inadequate treatment is necessary to determine their impact on patient outcomes...
The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomesE H Ibrahim
Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Washington University School of Medicine, Barnes-Jewish Hospital, Saint Louis, MO 63110, USA
Chest 120:555-61. 2001..More importantly, they should cooperate in the development of local multidisciplinary strategies aimed at the prevention of VAP and other nosocomial infections...
A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patientsM H Kollef
Department of Internal Medicine, Pulmonary and Critical Care Division, Washington University School of Medicine, St Louis, MO, USA
Chest 116:1339-46. 1999..To determine whether the application of continuous aspiration of subglottic secretions (CASS) is associated with a decreased incidence of ventilator-associated pneumonia (VAP)...
Epidemiology and risk factors for nosocomial pneumonia. Emphasis on preventionM H Kollef
Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri, USA
Clin Chest Med 20:653-70. 1999..To be successful, such quality improvement programs must be embraced at the institutional level. Only in this way can hospitals hope to successfully reduce their rates of VAP and sustain or improve upon those efforts over time...
Using protocols to improve the outcomes of mechanically ventilated patients. Focus on weaning and sedationE H Ibrahim
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, Barnes-Jewish Hospital, Saint Louis, Missouri, USA
Crit Care Clin 17:989-1001. 2001..Protocols are one method for potentially reducing those delays and ensuring that medical care is administered in a more standardized and efficient manner...
The effect of respiratory therapist-initiated treatment protocols on patient outcomes and resource utilizationM H Kollef
Department of Internal Medicine, Washington University School of Medicine, Barnes Jewish Hospital, St Louis, MO 63110, USA
Chest 117:467-75. 2000..Physicians frequently prescribe respiratory treatments to hospitalized patients, but the influence of such treatments on clinical outcomes is difficult to assess...
Antibiotic management of ventilator-associated pneumonia due to antibiotic-resistant gram-positive bacterial infectionM H Kollef
Washington University School of Medicine, Campus Box 8052, 660 South Euclid Avenue, St Louis, MO 63110, USA
Eur J Clin Microbiol Infect Dis 24:794-803. 2005..Studies are needed to define the optimal choice of antibiotic for pneumonias caused by this organism, and these choices will need to be balanced with the need to minimize the emergence of resistance...
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indicesMeghan N Jeffres
Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, MO, USA
Chest 130:947-55. 2006..Based on these results, aggressive dosing strategies for vancomycin (eg, trough concentrations of > 15 microg/mL) may not offer any advantage over traditional dose targets (range, 5 to 15 microg/mL)...
Before-after study of a standardized hospital order set for the management of septic shockScott T Micek
Department of Pharmacy, Barnes-Jewish Hospital, St Louis, MO, USA
Crit Care Med 34:2707-13. 2006..These data suggest that the use of standardized order sets for the management of septic shock should be routinely employed...
Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. databaseAndrew F Shorr
Washington Hospital Center, Washington, DC, USA
Crit Care Med 34:2588-95. 2006..To gain a better understanding of the epidemiology, microbiology, and outcomes of early-onset, culture-positive, community-acquired, healthcare-associated, and hospital-acquired bloodstream infections...
Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?Marin H Kollef
Department of Internal Medicine, Pulmonary and Critical Care Division, Washington University School of Medicine, Barnes Jewish Hospital, St Louis, Missouri, USA
Clin Infect Dis 43:S82-8. 2006..e., antibiotic heterogeneity) can be part of a broader effort aimed at curtailing antibiotic resistance within ICUs. Such efforts should be routine, given the limited availability of new antibiotic drug classes for the foreseeable future...
The intensive care unit as a research laboratory: developing strategies to prevent antimicrobial resistanceMarin H Kollef
Pulmonary and Critical Care Division, Washington University School of Medicine, Barnes Jewish Hospital, St Louis, Missouri 63110, USA
Surg Infect (Larchmt) 7:85-99. 2006..To assemble the available clinical data on the prevention of antimicrobial resistance in the intensive care unit (ICU) setting...
Providing appropriate antimicrobial therapy in the intensive care unit: surveillance vs. de-escalationMarin H Kollef
Crit Care Med 34:903-5. 2006
Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapyAndrew F Shorr
Pulmonary and Critical Care Medicine, Washington Hospital Center, Washington, DC, USA
Crit Care Med 34:700-6. 2006..Confronting the adverse impact of MRSA will require efforts that address more than the initial antibiotic prescription...
Optimizing antibiotic treatment for ventilator-associated pneumoniaScott T Micek
Department of Pharmacy, Barnes Jewish Hospital, St Louis, Missouri 63110, USA
Pharmacotherapy 26:204-13. 2006....
Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumoniaMarin H Kollef
Washington University School of Medicine, 660 South Euclid Ave, St Louis, MO 63110, USA
Chest 128:3854-62. 2005..Accumulating evidence suggests that health-care-associated infections are distinct from those that are truly community acquired...
Ventilator-associated pneumonia: insights from recent clinical trialsAndrew F Shorr
Pulmonary and Critical Care Medicine Service, Department of Medicine, Walter Reed Army Medical Center, Washington, DC, USA
Chest 128:583S-591S. 2005..This review highlights selected areas of new clinical research on VAP treatment and prevention in order to place their significance in context...
Staphylococcus aureus pneumonia: a "superbug" infection in community and hospital settingsMarin H Kollef
Chest 128:1093-7. 2005
Strategies to prevent antimicrobial resistance in the intensive care unitMarin H Kollef
Department of Internal Medicine, Pulmonary and Critical Care Division, Washington University School of Medicine, St Louis, MO 63110, USA
Crit Care Med 33:1845-53. 2005..To assemble the available clinical data for the prevention of antimicrobial resistance into practical recommendations for clinicians...
Time to get serious about infection prevention in the ICUMarin H Kollef
Chest 130:1293-6. 2006
Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trialMarin H Kollef
Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110, USA
JAMA 300:805-13. 2008..Ventilator-associated pneumonia (VAP) causes substantial morbidity. A silver-coated endotracheal tube has been designed to reduce VAP incidence by preventing bacterial colonization and biofilm formation...
Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteriaKatherine E Kollef
Washington University School of Medicine, St Louis, MO 63110, USA
Chest 134:281-7. 2008....
Health care-associated pneumonia: identification and initial management in the EDFredrick M Abrahamian
David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
Am J Emerg Med 26:1-11. 2008..The aim of this article is to create awareness of the entity known as HCAP and to provide knowledge of its identification and initial management in the emergency department...
Pneumonia caused by methicillin-resistant Staphylococcus aureusEthan Rubinstein
University of Manitoba, Winnipeg, Canada
Clin Infect Dis 46:S378-85. 2008..This article reviews the clinical features of, diagnosis of, and therapies for MRSA pneumonia...
Optimizing therapy for MRSA pneumoniaLee P Skrupky
Department of Pharmacy, Barnes Jewish Hospital, 216 S Kingshighway Boulevard, St Louis, MO 63110, USA
Semin Respir Crit Care Med 28:615-23. 2007..Other treatment options are limited, but new prospects are being investigated. This paper reviews the epidemiology and pharmacotherapy of MRSA pneumonia...
Correctly scoring infections: CSI in the ICUMarin H Kollef
Crit Care Med 35:2641-3. 2007
The modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus pneumoniaKatherine E Kollef
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, 660 South Euclid Ave, St Louis, MO 63110, USA
Chest 133:363-9. 2008....
Bugging the bugs: novel approaches in the strategic management of resistant Staphylococcus aureus infectionsMarin H Kollef
Medical Intensive Care Unit and Respiratory Care Services, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, MO 63110, USA
Clin Infect Dis 45:S163-4. 2007
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumoniaMeghan N Jeffres
Department of Pharmacy, Barnes Jewish Hospital, St Louis, Missouri, USA
Clin Ther 29:1107-15. 2007....
Health care-associated pneumonia and community-acquired pneumonia: a single-center experienceScott T Micek
Department of Pharmacy, Barnes Jewish Hospital, St Louis, MO, USA
Antimicrob Agents Chemother 51:3568-73. 2007..Health care providers should differentiate patients with HCAP from those with CAP in order to provide more appropriate initial antimicrobial therapy...
Analysis of 30-day mortality for clostridium difficile-associated disease in the ICU settingClaire Kenneally
Washington University School of Medicine, 660 South Euclid Ave, Campus Box 8052, St Louis, MO 63110, USA
Chest 132:418-24. 2007..To examine the 30-day mortality rate among patients with Clostridium difficile-associated disease (CDAD) requiring intensive care...
The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infectionsJames A Driscoll
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA
Drugs 67:351-68. 2007..Multidrug-resistant P. aeruginosa may require treatment with less commonly used antibacterials (e.g. colistin), but newer anti-pseudomonal antibacterials are expected to be available in the near future...
Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundiiEli N Deal
Department of Pharmacy, Barnes Jewish Hospital, St Louis, Missouri 63110, USA
Pharmacotherapy 27:191-9. 2007..To identify predictors of in-hospital mortality among patients with bacteremia caused by Enterobacter cloacae, Enterobacter aerogenes, or Citrobacter freundii...
Increasing incidence of sterile-site infections due to non-multidrug-resistant, oxacillin-resistant Staphylococcus aureus among hospitalized patientsGarrett E Schramm
Department of Pharmacy, Barnes Jewish Hospital, St Louis, MO 63110, USA
Infect Control Hosp Epidemiol 28:95-7. 2007..The annual percentage of MRSA isolates from cases of healthcare-associated and hospital-acquired infection that were susceptible to 3 or more non- beta -lactam antibiotics increased significantly...
Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumoniaAndrew F Shorr
Pulmonary and Critical Care Medicine Service, Washington Hospital Center, Washington, District of Columbia, USA
Crit Care 10:R97. 2006....
Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patientsScott T Micek
Department of Pharmacy Barnes-Jewish Hospital St. Louis, MO, USA
Crit Care Med 33:1260-5. 2005..Additional studies are required to determine how the use of these specific interventions influences the occurrence and the natural history of delirium among critically ill patients...
Ventilator-associated pneumonia in a multi-hospital system: differences in microbiology by locationHilary M Babcock
Division of Infectious Diseases, Washington University School of Medicine, USA
Infect Control Hosp Epidemiol 24:853-8. 2003..CONCLUSIONS: Microbiologic etiologies of ventilator-associated pneumonia vary between and within hospitals. Knowledge of these differences can improve selection of initial antimicrobial regimens, which may decrease mortality...
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumoniaRichard G Wunderink
Methodist Healthcare Memphis and the University of Tennessee, Memphis, TN 38104 3499, USA
Chest 124:1789-97. 2003..To assess the effect of baseline variables, including treatment, on outcome in patients with nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA)...
The influence of infection on hospital mortality for patients requiring > 48 h of intensive careSteven Osmon
Pulmonary and Critical Care Division, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA
Chest 124:1021-9. 2003....
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumoniaRichard G Wunderink
Methodist Healthcare Memphis and the University of Tennessee, Memphis, Tennessee 38104 3499, USA
Clin Ther 25:980-92. 2003....
Antibiotic heterogeneity: should we use it?Marin H Kollef
Crit Care Med 31:2074-6. 2003
The epidemiology of vancomycin-resistant Enterococcus colonization in a medical intensive care unitDavid K Warren
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri 63110, USA
Infect Control Hosp Epidemiol 24:257-63. 2003..This was likely due in large part to prior VRE exposures in the rest of the hospital where these control measures were not being used...
An empirical approach to the treatment of multidrug-resistant ventilator-associated pneumoniaMarin H Kollef
Clin Infect Dis 36:1119-21. 2003
Clinical utility of blood cultures drawn from central vein catheters and peripheral venipuncture in critically ill medical patientsMichelle Beutz
Pulmonary and Critical Care Division, Washington University School of Medicine, St. Louis 63110, USA
Chest 123:854-61. 2003..Clinicians should also be aware that additional blood samples may be necessary when interpreting positive blood culture results for common skin or central vein catheter contaminants...
Treatment of ventilator-associated pneumonia: get it right from the startMarin H Kollef
Crit Care Med 31:969-70. 2003
Epidemiology and outcomes of ventilator-associated pneumonia in a large US databaseJordi Rello
University Hospital Joan XXIII, University Rovira and Virgili, Tarragona, Spain
Chest 122:2115-21. 2002..While strategies to prevent the occurrence of VAP may not reduce mortality, they may yield other important benefits to patients, their families, and hospital systems...
Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumoniaJeanne E Zack
Department of Hospital Epidemiology, Barnes-Jewish Hospital, St. Louis, MO, USA
Crit Care Med 30:2407-12. 2002..Education programs should be more widely employed for infection control in the intensive care unit setting and can lead to substantial decreases in cost and patient morbidity attributed to hospital-acquired infections...
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumoniaManuel Iregui
Pulmonary and Critical Care Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
Chest 122:262-8. 2002..Clinicians should avoid delaying the administration of appropriate antibiotic treatment to patients with VAP in order to minimize their risk of mortality...
Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxisEmad H Ibrahim
Pulmonary and Critical Care Division, Washington University School of Medicine, St. Louis, MO, USA
Crit Care Med 30:771-4. 2002..Additionally, early detection methods should be considered to reduce the potential morbidity associated with untreated DVT in this high-risk population...
Endotracheal tube intraluminal volume loss among mechanically ventilated patientsChirag Shah
Pulmonary and Critical Care Division, Washington University School of Medicine, St. Louis, MO 63110, USA
Crit Care Med 32:120-5. 2004..5 +/- 0.4 vs. 6.7 +/- 1.2 mm, p <.001). CONCLUSIONS: Endotracheal tube intraluminal volume loss is common among patients with acute respiratory failure requiring mechanical ventilation and increases with prolonged tracheal intubation...
Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycinAndrew F Shorr
Pulmonary and Critical Care Medicine Service, Walter Reed Army Medical Center, Washington, DC, USA
Crit Care Med 32:137-43. 2004..CONCLUSIONS: Linezolid is a cost-effective alternative to vancomycin for the treatment of ventilator-associated pneumonia...
Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosaStephen Osmon
Pulmonary and Critical Care Division, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA
Chest 125:607-16. 2004..CONCLUSIONS: These data suggest that bloodstream infections due to P aeruginosa have a greater risk of hospital mortality compared to bloodstream infections due to S aureus despite adequate antibiotic treatment...
Prevention of pneumonia in the hospital settingStephen B Osmon
Pulmonary and Critical Care Division, Washington University School of Medicine, Campus Box 8052, 660 South Euclid Avenue, St. Louis, MO 63110, USA
Clin Chest Med 26:135-42. 2005..Given the evidence supporting greater morbidity, hospital mortality, and medical care costs among patients who have VAP, the prevention of this nosocomial infection should be an important priority in the hospital setting...
Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatmentScott T Micek
Department of Pharmacy, Barnes-Jewish Hospital, Washington University School of Medicine, 660 South Euclid Ave, Campus Box 8052, St. Louis, Missouri 63110, USA
Antimicrob Agents Chemother 49:1306-11. 2005..aeruginosa bloodstream infection. Inappropriate antimicrobial treatment of P. aeruginosa bloodstream infections may be minimized by increased use of combination antimicrobial treatment until susceptibility results become known...
Prevention of hospital infectionDavid K Warren
Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, MO, USA
Microbes Infect 7:268-74. 2005..These infection-control policies also require the presence of a dedicated group of infection-control practitioners to provide education, collect surveillance data, and oversee the implementation of the local infection-control plan...
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trialAndrew F Shorr
Pulmonary and Critical Care Medicine Service, Walter Reed Army Medical Center, Washington, DC 20307, USA
Clin Infect Dis 40:S123-9. 2005..imipenem-cilastatin) was not predictive of outcomes, thus suggesting that the treatment regimens were equivalent. Both levofloxacin and imipenem-cilastatin regimens were well tolerated and had similar adverse event profiles...
Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysisAndrew F Shorr
Walter Reed Army Medical Center, Washington, DC, USA
Crit Care Med 33:46-53. 2005..Invasive strategies do not alter mortality. Invasive approaches to ventilator-associated pneumonia affect antibiotic use and prescribing...
Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patientsDavid K Warren
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Crit Care Med 32:2450-6. 2004..To determine the impact of the rotation of antimicrobial agents on the rates of infection, intestinal colonization, and acquisition with antimicrobial-resistant Gram-negative bacteria...
Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenemsMarin H Kollef
Department of Internal Medicine, Pulmonary Critical Care Medicine, Washington University School of Medicine, Campus Box 8052, 660 South Euclid Avenue, St Louis MO 63110, USA
Respir Care 49:1530-41. 2004..The carbapenems are active against both Gram-positive and Gram-negative pathogens, including anaerobes; resistance to carbapenems remains rare...
The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICUDavid K Warren
Washington University School of Medicine, 660 South Euclid Ave, Campus Box 8052, St. Louis, MO 63110, USA
Chest 126:1612-8. 2004..Education programs may lead to a substantial decrease in medical-care costs and patient morbidity attributed to central venous catheterization when implemented as part of mandatory training...
Effects of an antibiotic cycling program on antibiotic prescribing practices in an intensive care unitLiana R Merz
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri 63110, USA
Antimicrob Agents Chemother 48:2861-5. 2004..In conclusion, the successful implementation of this cycling protocol increased antibiotic heterogeneity over time in the study unit...
An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effectsHilary M Babcock
Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO, USA
Chest 125:2224-31. 2004..To determine whether an educational initiative could decrease rates of ventilator-associated pneumonia in a regional health-care system...
Risk factors for ventilator-associated pneumonia: from epidemiology to patient managementMarc J M Bonten
Department of Internal Medicine, Division of Acute Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, The Netherlands
Clin Infect Dis 38:1141-9. 2004..In settings with high levels of antibiotic resistance, combined approaches of non-antibiotic using strategies and education programs might be most beneficial...
Red blood cell transfusion and ventilator-associated pneumonia: A potential link?Andrew F Shorr
Pulmonary and Critical Care Medicine Service, Walter Reed Army Medical Center, Washington, DC, USA
Crit Care Med 32:666-74. 2004..To determine the relationship between packed red blood cell transfusion practice and the development of ventilator-associated pneumonia (VAP)...
Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unitDavid K Warren
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri 63110, USA
Infect Control Hosp Epidemiol 25:99-104. 2004..The recent emergence of vancomycin-resistant Staphylococcus aureus and the presence of a patient population co-colonized or co-infected with VRE and MRSA support the need for aggressive infection control measures in the ICU...
Determinants of outcome for patients admitted to a long-term ventilator unitManuel Iregui
Pulmonary and Critical Care Division, Washington University School of Medicine, St. Louis, MO 63110, USA
South Med J 95:310-7. 2002....
